Regenerative medicine seeks to repair, replace, or restore damaged cells, tissues, and organs by harnessing the body's healing mechanisms or by supplying engineered biological systems. It includes cell therapy, gene therapy, tissue engineering, biomaterials, organoids, extracellular vesicles, and bioactive molecules. In nanotechnology and biotechnology, regenerative medicine uses nanoscale cues, delivery systems, scaffolds, and interfaces to influence cell fate, immune response, vascularization, and tissue integration.
Regenerative medicine matters because many chronic injuries, degenerative diseases, and organ failures cannot be solved by replacement parts or drugs alone. Research targets musculoskeletal repair, wound healing, nerve regeneration, cardiovascular disease, diabetes, liver disease, and immune modulation. Nanoscale materials can deliver growth factors, guide stem-cell differentiation, mimic extracellular matrix, and support controlled tissue remodeling. The field connects closely to tissue engineering, biomaterials, and cell therapy.
Conferences on regenerative medicine appear in biotechnology, medicine, biomaterials, tissue engineering, stem-cell research, and nanomedicine programs. Sessions often cover cell therapies, scaffolds, biofabrication, exosomes, immune engineering, and clinical translation. Tracking regenerative-medicine events helps researchers follow a field where advanced materials and living systems converge to restore biological function.
To learn more, read our detailed glossary article on regenerative medicine.